ImmunologybioRxivPreprint
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine
A. Grandi, M. Tomasi, S. Accordini…·G. Grandi
This study demonstrates that OMV-based SARS-CoV-2 vaccines induce neutralizing antibodies and protect mice from viral challenge.
DOI 10.1101/2021.07.12.452027